Ono Pharmaceutical Co., Ltd. (TYO:4528)
Japan · Delayed Price · Currency is JPY 2,388.50
-16.50 (-0.69%)
Jul 23, 2026, 2:54 PM JST
Ono Pharmaceutical Earnings Call Transcripts
Fiscal Year 2026
-
The presentation outlined a robust global growth strategy, emphasizing the Deciphera acquisition, OPDIVO life cycle management, and a strong pipeline with multiple high-potential launches planned through 2031. Financial outlook remains positive, with sustained R&D investment and confidence in overcoming the OPDIVO patent cliff.